DekaBank Deutsche Girozentrale’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Hold |
39,000
| – | – | ﹤0.01% | 816 |
|
|
2025
Q1 | $1.31M | Hold |
39,000
| – | – | ﹤0.01% | 803 |
|
|
2024
Q4 | $1.5M | Hold |
39,000
| – | – | ﹤0.01% | 803 |
|
|
2024
Q3 | $1.5M | Hold |
39,000
| – | – | ﹤0.01% | 815 |
|
|
2024
Q2 | $1.46M | Hold |
39,000
| – | – | ﹤0.01% | 814 |
|
|
2024
Q1 | $1.67M | Hold |
39,000
| – | – | ﹤0.01% | 795 |
|
|
2023
Q4 | $1.8M | Buy |
39,000
+19,000
| +95% | +$877K | ﹤0.01% | 791 |
|
|
2023
Q3 | $707K | Hold |
20,000
| – | – | ﹤0.01% | 940 |
|
|
2023
Q2 | $772K | Hold |
20,000
| – | – | ﹤0.01% | 929 |
|
|
2023
Q1 | $708K | Hold |
20,000
| – | – | ﹤0.01% | 948 |
|
|
2022
Q4 | $781K | Hold |
20,000
| – | – | ﹤0.01% | 944 |
|
|
2022
Q3 | $721K | Buy |
20,000
+7,600
| +61% | +$274K | ﹤0.01% | 963 |
|
|
2022
Q2 | $378K | Hold |
12,400
| – | – | ﹤0.01% | 1072 |
|
|
2022
Q1 | $373K | Buy |
12,400
+1,100
| +10% | +$33.1K | ﹤0.01% | 1113 |
|
|
2021
Q4 | $359K | Buy |
11,300
+300
| +3% | +$9.53K | ﹤0.01% | 1168 |
|
|
2021
Q3 | $162K | Hold |
11,000
| – | – | ﹤0.01% | 1242 |
|
|
2021
Q2 | $196K | Hold |
11,000
| – | – | ﹤0.01% | 1224 |
|
|
2021
Q1 | $190K | Hold |
11,000
| – | – | ﹤0.01% | 1190 |
|
|
2020
Q4 | $157K | Buy |
+11,000
| New | +$157K | ﹤0.01% | 1213 |
|